Albemarle (ALB) Announces Expansion at South Haven, MI Site

June 26, 2012 4:15 PM EDT Send to a Friend
Albemarle Corporation (NYSE: ALB) announced today that its FDA-registered South Haven, Michigan site has expanded and upgraded its multi-product cGMP active pharmaceutical ingredient (API) manufacturing facility. Production using the new expanded capacity commenced on June 1, 2012.

This expansion is the latest in a series of projects at the South Haven site to increase capabilities and production throughput, meeting the increasing demand for both generic API products and custom manufacturing service portfolios. In the past two years, the number of custom API projects has more than doubled at the South Haven site.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Corporate News

Add Your Comment